Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares ESG Aware 60/40 Balanced Allocation ETF (NY:EAOR)

34.51 -0.29 (-0.84%)
Official Closing Price Updated: 8:00 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares ESG Aware 60/40 Balanced Allocation ETF

< Previous 1 2 Next >
News headline image
BBWI Stock Cracks Pre-Market After CEO Warns Of Softer Q3, Slashes Full-Year Guidance ↗
The company said it was revising its full-year 2025 net sales guidance to a decline in the low single digits, compared with the previous forecast of 1.5% to 2.7% growth. 
Via Stocktwits
News headline image
Joby Aviation To Launch Electric Air Taxi Test Flights In Saudi Arabia ↗
The company said that under the agreement, Joby will work together with Red Sea Global and The Helicopter Company to establish a "sandbox" for pre-commercial operations. 
Via Stocktwits
Topics Artificial Intelligence
AVXL Stock Draws Retail Attention Ahead Of Company’s Meeting With EMA Committee ↗
Via Stocktwits
News headline image
Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates ↗
The company noted that it is on track to deliver about $7.2 billion in overall anticipated net cost savings by the end of 2027. 
Via Stocktwits
Topics Artificial Intelligence World Trade
BMY CEO Expects Cancer Drug Opdivo To Drive Strong Sales In 2025 ↗
Via Stocktwits
JHG Stock Rockets 15% Pre-Market After Receiving A Non-Binding Proposal For $46 Per Share ↗
Via Stocktwits
Hillenbrand To Go Private In Nearly $4B Deal With Affiliate Of Lone Star Funds ↗
Via Stocktwits
ASTS Stock Hit Fresh All-Time Highs Today: What’s Driving The Investor Buzz? ↗
Via Stocktwits
Planet Labs To Provide Images Within An Hour Using New Earth Observation Satellites: Report ↗
Via Stocktwits
News headline image
BridgeBio Shares Second Positive Late-Stage Study Result In A Week – Calcium Disorder Drug Trial Yields Positive Results ↗
76% of the 67 participants administered Encaleret in the trial achieved both serum and urine calcium within the respective target ranges after 24 weeks of treatment. 
Via Stocktwits
News headline image
Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices ↗
Organon said that the investigation found that certain wholesalers in the United States were asked to buy more Nexplanon than they needed. 
Via Stocktwits
News headline image
Albemarle To Sell Majority Stake In Ketjen’s Refining Catalyst Business To KPS Capital Partners ↗
The company said that Albemarle and KPS, through affiliates, will own about 49% and 51% of Ketjen at close, respectively. 
Via Stocktwits
News headline image
UnitedHealth’s Optum CFO Reportedly Exits In Less Than Six Months Into The Role ↗
Roger Connor is leaving the role to return to the U.K. to be closer to family, according to a Bloomberg report on Thursday, citing an internal memo. 
Via Stocktwits
Plug Power Names Insider Jose Luis Crespo As New CEO ↗
Via Stocktwits
UnitedHealth Shareholder Proposes Distinct Chairman And Chief Executive Roles: Report ↗
Via Stocktwits
Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update ↗
Via Stocktwits
Amgen Announces $650M Expansion Of US Manufacturing Network After Trump’s Pharma Tariff Announcement ↗
Via Stocktwits
Topics Government
News headline image
Applied Digital Stock Soars 7% Pre-Market On $5B AI Factory Lease With US Hyperscaler ↗
Applied Digital said that this was a nearly 15-year lease agreement to deliver 200 MW of critical IT capacity at Polaris Forge 2. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Humana Stock Slumps After Reportedly Losing Lawsuit Seeking To Undo Cuts To Medicare Bonus Payments ↗
Bloomberg reported on Tuesday that a Texas judge ruled in favor of the federal government, affirming a downgrade of quality ratings that are tied to payments for Medicare Advantage. 
Via Stocktwits
Topics Lawsuit
Uber Reportedly Expects Non-Restaurant Deliveries To Surge Faster Than Previously Expected ↗
Via Stocktwits
Acadia Healthcare Stock Surges Pre-Market After Activist Hedge Fund Reportedly Seeks Board Revamp ↗
Via Stocktwits
Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease ↗
Via Stocktwits
Scholar Rock In Spotlight After FDA Refuses To Approve Muscular Atrophy Treatment Over Third-Party Manufacturing Facility Issues ↗
Via Stocktwits
Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study ↗
Via Stocktwits
Oklo Stock Continues To Be The Talk Of The Town After Gaining 87% In A Month – Here’s How Retail Investors Responded ↗
Via Stocktwits
Cracker Barrel In Spotlight After Slew Of Price Target Cuts: Citi Says Q1 Began In A ‘Deep Traffic Hole’ Post Logo Change ↗
Via Stocktwits
News headline image
Duolingo Stock Dips After Citigroup Lowers Price Target – Here’s What The Analyst Said About Duocon Event ↗
Citigroup maintained a ‘Buy’ rating and noted that Duolingo's product announcements this year had a lower profile relative to the past. 
Via Stocktwits
Topics Artificial Intelligence
RH Stock Sees Slew Of Downgrades, Price Target Cuts From Wall Street As Trump Tariffs Bite ↗
Via Stocktwits
Topics Government
News headline image
Soleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details Inside ↗
Soleno said that its assessment of the death is the same as the treating physician, who said that the death is not related to the treatment with Vykat XR. 
Via Stocktwits
Topics Death
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study ↗
After 48 weeks, patients receiving 30 mg once-daily oral Blarcamesine demonstrated barely detectable cognitive decline, the company said. 
Via Stocktwits
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.